NASDAQ : ASTH
Astrana Health, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 36.53 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 1.87B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.87B |
| Enterprise Value | 2.45B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 51.17M |
| Shares Outstanding | 51.17M |
| Shares Change (YoY) | +1.73% |
| Shares Change (QoQ) | +1.48% |
| Owned by Insiders (%) | 10.72% |
| Owned by Institutions (%) | 63.58% |
| Float | 45.67M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 44.55 |
| Forward PE | 21.68 |
| PS Ratio | 0.49 |
| Forward PS | 0.45 |
| PB Ratio | 2.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.81 |
| P/OCF Ratio | 17.33 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 60.37 |
| EV / Sales | 0.64 |
| EV / EBITDA | 14.00 |
| EV / EBIT | 21.88 |
| EV / FCF | 25.94 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.23 |
| Quick Ratio | 1.19 |
| Debt / Equity | 1.64 |
| Debt / EBITDA | 5.09 |
| Debt / FCF | 10.38 |
| Interest Coverage | 1.55 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 6.90% |
| Return on Assets (ROA) | 3.76% |
| Return on Invested Capital (ROIC) | 6.24% |
| Return on Capital Employed (ROCE) | 7.29% |
| Weighted Average Cost of Capital (WACC) | 8.18% |
| Revenue Per Employee | $1.28M |
| Profits Per Employee | $13,516 |
| Employee Count | 3,000 |
| Asset Turnover | 2.06 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 20.87M |
| Effective Tax Rate | 34.73% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +9.87% |
| 50-Day Moving Average | 37.09 |
| 200-Day Moving Average | 33.84 |
| Relative Strength Index (RSI) | 46.72 |
| Average Volume (20 Days) | 294,189 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.01M |
| Short Previous Month | 3.09M |
| Short % of Shares Out | 5.88% |
| Short % of Float | 6.59% |
| Short Ratio (days to cover) | 6.90 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.84B |
| Gross Profit | 402.00M |
| Operating Income | 111.88M |
| Pretax Income | 60.10M |
| Net Income | 40.55M |
| EBITDA | 174.91M |
| EBIT | 111.88M |
| Earnings Per Share (EPS) | $0.82 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 400.79M |
| Total Debt | 979.41M |
| Net Cash | -578.62M |
| Net Cash Per Share | -$11.31 |
| Equity (Book Value) | 598.58M |
| Book Value Per Share | 16.87 |
| Working Capital | 171.52M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 107.87M |
| Capital Expenditures | -13.49M |
| Depreciation & Amortization | 63.03M |
| Net Borrowing | 539.44M |
| Free Cash Flow | 94.38M |
| FCF Per Share | $1.84 |
Margins
| Measure | Value |
|---|
| Gross Margin | 10.46% |
| Operating Margin | 2.91% |
| Pretax Margin | 1.56% |
| Profit Margin | 1.05% |
| EBITDA Margin | 4.55% |
| EBIT Margin | 2.91% |
| FCF Margin | 2.46% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.73% |
| Shareholder Yield | -1.73% |
| Earnings Yield | 2.24% |
| FCF Yield | 5.05% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $51.67 |
| Price Target Difference | 41.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 14.91% |
| EPS Growth Forecast (3Y) | 28.75% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.63 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |